Cite

HARVARD Citation

    Guo, B. et al. (2021). A Bayesian Phase I/II Design for Cancer Clinical Trials Combining an Immunotherapeutic Agent with a Chemotherapeutic Agent. Journal of the Royal Statistical Society. 70 (5), pp. 1210-1229. [Online]. 
  
Back to record